全文获取类型
收费全文 | 3202篇 |
免费 | 314篇 |
出版年
2021年 | 42篇 |
2019年 | 36篇 |
2018年 | 43篇 |
2017年 | 30篇 |
2016年 | 40篇 |
2015年 | 100篇 |
2014年 | 123篇 |
2013年 | 147篇 |
2012年 | 164篇 |
2011年 | 144篇 |
2010年 | 107篇 |
2009年 | 87篇 |
2008年 | 143篇 |
2007年 | 124篇 |
2006年 | 114篇 |
2005年 | 115篇 |
2004年 | 95篇 |
2003年 | 102篇 |
2002年 | 96篇 |
2001年 | 109篇 |
2000年 | 108篇 |
1999年 | 103篇 |
1998年 | 54篇 |
1997年 | 34篇 |
1996年 | 39篇 |
1995年 | 34篇 |
1994年 | 42篇 |
1993年 | 30篇 |
1992年 | 54篇 |
1991年 | 56篇 |
1990年 | 61篇 |
1989年 | 64篇 |
1988年 | 57篇 |
1987年 | 49篇 |
1986年 | 54篇 |
1985年 | 53篇 |
1984年 | 42篇 |
1983年 | 27篇 |
1982年 | 35篇 |
1980年 | 28篇 |
1979年 | 28篇 |
1978年 | 39篇 |
1976年 | 34篇 |
1975年 | 36篇 |
1974年 | 31篇 |
1973年 | 29篇 |
1972年 | 31篇 |
1971年 | 36篇 |
1970年 | 29篇 |
1969年 | 34篇 |
排序方式: 共有3516条查询结果,搜索用时 15 毫秒
141.
142.
Forin Silvia Berger Markus Finkbeiner Matthias 《The International Journal of Life Cycle Assessment》2020,25(4):663-666
The International Journal of Life Cycle Assessment - 相似文献
143.
Viere Tobias Amor Ben Berger Nicolas Fanous Ruba Dolfing Arduin Rachel Horta Keller Regula Laurent Alexis Loubet Philippe Strothmann Philip Weyand Steffi Wright Laurie Sonnemann Guido 《The International Journal of Life Cycle Assessment》2021,26(3):511-527
The International Journal of Life Cycle Assessment - Scientific Life Cycle Assessment (LCA) literature provides some examples of LCA teaching in higher education, but not a structured overview of... 相似文献
144.
Mahamat Alhadj Moussa Ibrahim Judith Sophie Weber Sen Claudine Henriette Ngomtcho Djoukzoumka Signaboubo Petra Berger Hassane Mahamat Hassane Srge Kelm 《PLoS neglected tropical diseases》2021,15(6)
BackgroundAfrican trypanosomes are parasites mainly transmitted by tsetse flies. They cause trypanosomiasis in humans (HAT) and animals (AAT). In Chad, HAT/AAT are endemic. This study investigates the diversity and distribution of trypanosomes in Mandoul, an isolated area where a tsetse control campaign is ongoing, and Maro, an area bordering the Central African Republic (CAR) where the control had not started.Methods717 human and 540 cattle blood samples were collected, and 177 tsetse flies were caught. Trypanosomal DNA was detected using PCR targeting internal transcribed spacer 1 (ITS1) and glycosomal glyceraldehyde-3 phosphate dehydrogenase (gGAPDH), followed by amplicon sequencing.ResultsTrypanosomal DNA was identified in 14 human samples, 227 cattle samples, and in tsetse. Besides T. b. gambiense, T. congolense was detected in human in Maro. In Mandoul, DNA from an unknown Trypanosoma sp.-129-H was detected in a human with a history of a cured HAT infection and persisting symptoms. In cattle and tsetse samples from Maro, T. godfreyi and T. grayi were detected besides the known animal pathogens, in addition to T. theileri (in cattle) and T. simiae (in tsetse). Furthermore, in Maro, evidence for additional unknown trypanosomes was obtained in tsetse. In contrast, in the Mandoul area, only T. theileri, T. simiae, and T. vivax DNA was identified in cattle. Genetic diversity was most prominent in T. vivax and T. theileri.ConclusionTsetse control activities in Mandoul reduced the tsetse population and thus the pathogenic parasites. Nevertheless, T. theileri, T. vivax, and T. simiae are frequent in cattle suggesting transmission by other insect vectors. In contrast, in Maro, transhumance to/from Central African Republic and no tsetse control may have led to the high diversity and frequency of trypanosomes observed including HAT/AAT pathogenic species. Active HAT infections stress the need to enforce monitoring and control campaigns. Additionally, the diverse trypanosome species in humans and cattle indicate the necessity to investigate the infectivity of the unknown trypanosomes regarding their zoonotic potential. Finally, this study should be widened to other trypanosome hosts to capture the whole diversity of circulating trypanosomes. 相似文献
145.
146.
Imre Berger Martin Egli Nada Spackova Jiri Sponer Alexander Rich 《Nucleosides, nucleotides & nucleic acids》2013,32(6-7):1583-1585
Abstract DNA fragments with stretches of cytosine residues can form four-stranded intercalated i-DNA molecules stabilized by hemiprotonated cytosine·cytosine+ (C·C+) base pairs. Intriguing features of this motif are the accomodation of base stacking that is unfavorable due to electrostatic repulsion and the close approach of phosphates in narrow grooves of the molecule. Unusual sources of stability in this structure involve sugar-base stacking and CH-O interribose short contacts between the backbones of adjacent strands. 相似文献
147.
T. M. Berger N. Rifai M. E. Avery 《Redox report : communications in free radical research》2013,18(4):257-262
SummaryPlasma concentrations of vitamin C (ascorbic acid, AA) are known to be higher in full-term human neonates than their mothers. Immaturity of placental AA transport could result in low plasma AA concentrations in pre-term infants. We found that plasma AA concentrations in umbilical cord blood of 25 full-term neonates (38–42 weeks gestation) and 33 pre-term neonates (24–36 weeks gestation) were always significantly higher than in the corresponding maternal blood (P < 0.0001). However, plasma AA levels were significantly higher in pre-term than in full-term infants (146 ± 93 vs 102 ± 27 μM, respectively; P = 0.03). Furthermore, a rapid and sharp decrease in plasma AA concentrations from 229 ± 166 μM to 45 ± 18 μM (P < 0.0001) over the first 3 days of life was observed in eight very low birth weight infants (460–1090 g, 24–28 weeks gestation). These findings raise important questions about the in utero functions of AA in the developing fetus and the adequacy of postnatal vitamin C supplementation of the premature infant. 相似文献
148.
Anita Rózsás Judit Berta Lívia Rojkó László Z. Horváth Magdolna Keszthelyi István Kenessey Viktória László Walter Berger Michael Grusch Mir Alireza Hoda Szilvia T?r?k Walter Klepetko Ferenc Rényi-Vámos Balázs Heged?s Balázs D?me József Tóvári 《PloS one》2013,8(10)
Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling in human non-small cell lung cancer (NSCLC) also remains controversial, our aim was to study whether EPO treatment modifies tumor growth and if EPOR expression has an impact on the clinical behavior of this malignancy. A total of 43 patients with stage III–IV adenocarcinoma (ADC) and complete clinicopathological data were included. EPOR expression in human ADC samples and cell lines was measured by quantitative real-time polymerase chain reaction. Effects of exogenous rHuEPOα were studied on human lung ADC cell lines in vitro. In vivo growth of human ADC xenografts treated with rHuEPOα with or without chemotherapy was also assessed. In vivo tumor and endothelial cell (EC) proliferation was determined by 5-bromo-2’-deoxy-uridine (BrdU) incorporation and immunofluorescent labeling. Although EPOR mRNA was expressed in all of the three investigated ADC cell lines, rHuEPOα treatment (either alone or in combination with gemcitabine) did not alter ADC cell proliferation in vitro. However, rHuEPOα significantly decreased tumor cell proliferation and growth of human H1975 lung ADC xenografts. At the same time, rHuEPOα treatment of H1975 tumors resulted in accelerated tumor endothelial cell proliferation. Moreover, in patients with advanced stage lung ADC, high intratumoral EPOR mRNA levels were associated with significantly increased overall survival. This study reveals high EPOR level as a potential novel positive prognostic marker in human lung ADC. 相似文献
149.
Guillaume Nugue Marie Bidart Marie Arlotto Mireille Mousseau Fran?ois Berger Laurent Pelletier 《PloS one》2013,8(8)
Developing therapeutic monoclonal antibodies paves the way for new strategies in oncology using targeted therapy which should improve specificity. However, due to a lack of biomarkers, a personalized therapy scheme cannot always be applied with monoclonal antibodies. As a consequence, the efficacy or side effects associated with this type of treatment often appear to be sporadic. Bevacizumab is a therapeutic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF). It is used to limit tumor vascularization. No prognosis or response biomarker is associated with this antibody, we therefore assessed whether the administration protocol could be a possible cause of heterogeneous responses (or variable efficacy). To do this, we developed a bevacizumab assay with a broad sensitivity range to measure blood bevacizumab concentrations. We then analyzed bevacizumab concentrations in 17 patients throughout the first quarter of treatment. In line with previously published data, average blood concentrations were 88+/−27 mg/L following the first dose administered, and 213+/−105 mg/L after the last (6th) dose administered. However, the individual values were scattered, with a mean 4-fold difference between the lowest and the highest concentration for each dose administered. We demonstrated that the bevacizumab administration schedule results in a high inter-individual variability in terms of blood concentrations. Comparison of assay data with clinical data indicates that blood concentrations above the median are associated with side effects, whereas values below the median favor inefficacy. In conclusion, bevacizumab-based therapy could benefit from a personalized administration schedule including follow-up and adjustment of circulating bevacizumab concentrations. 相似文献
150.
Marion Fiorentino Guillaume Bastard Malick Sembène Sonia Fortin Pierre Traissac Edwige Landais Christèle Icard-Vernière Frank T. Wieringa Jacques Berger 《PloS one》2013,8(12)